The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort
Open accessAbstract
BACKGROUND: It is unknown if antidepressant treatment is associated with either increased or decreased risk of suicide. OBJECTIVE: To estimate the risk of suicide, attempted suicide, and overall mortality during antidepressant treatments in a real-life setting with high statistical power. DESIGN AND SETTING: A cohort study in which all subjects without psychosis, hospitalized because of a suicide attempt from January 1, 1997, to December 31, 2003, in Finland, were followed up through a nationwide computerized database. PARTICIPANTS: A total of 15 390 patients with a mean follow-up of 3.4 years. MAIN OUTCOME MEASURES: The propensity score-adjusted relative risks (RRs) during monotherapy with the most frequently used antidepressants compared with no antidepressant treatment. RESULTS: In the entire cohort, fluoxetine use was associated with the lowest risk (RR, 0.52; 95% confidence interval [CI], 0.30-0.93), and venlafaxine hydrochloride use with the highest risk (RR, 1.61; 95% CI, 1.01-2.57), of suicide. A substantially lower mortality was observed during selective serotonin reuptake inhibitor use (RR, 0.59; 95% CI, 0.49-0.71; P<.001), and this was attributable to a decrease in cardiovascular- and cerebrovascular-related deaths (RR, 0.42; 95% CI, 0.24-0.71; P=.001). Among subjects who had ever used any antidepressant, the current use of medication was associated with a markedly increased risk of attempted suicide (39%, P<.001), but also with a markedly decreased risk of completed suicide (-32%, P=.002) and mortality (-49%, P<.001), when compared with no current use of medication. The results for subjects aged 10 to 19 years were basically the same as those in the total population, except for an increased risk of death with paroxetine hydrochloride use (RR, 5.44; 95% CI, 2.15-13.70; P<.001). CONCLUSIONS: Among suicidal subjects who had ever used antidepressants, the current use of any antidepressant was associated with a markedly increased risk of attempted suicide and, at the same time, with a markedly decreased risk of completed suicide and death. Lower mortality was attributable to a decrease in cardiovascular- and cerebrovascular-related deaths during selective serotonin reuptake inhibitor use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some observational studies and a secondary analysis from a psychotherapy trial in cardiac patients have found that prescription of antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs), is associated with lower rates of cardiovascular mortality 167,168 or MI. 169”
From Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association (2021) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. V. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 3,104
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,006
Ovarian cancer and hormone replacement therapy in the Million Women Study
Beral, V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60534-0 · Cited by 937
Endometrial cancer and hormone-replacement therapy in the Million Women Study
Beral, V., Bull, D., & REEVES, G. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66455-0 · Cited by 627
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 587
Taylor, C. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.792 · Cited by 512
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Flagged first, then by citations
Research works printed but not linked: 2
- Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S. Secular trends in anti- depressant prescribing in the UK, 1975-1988. J Public Health Med. 2001;23: 262-267.
- Lo ¨nnqvist J, Henriksson M, Isometsa ¨E, Marttunen M, Heikkinen M. Itsetuhoka ¨y- tta ¨ytyminen ja itsemurhat. In: Lo ¨nnqvist J, Heikkinen M, Henriksson M, Mart- tunen M, Partonen T, eds. Psykiatria. Ha ¨meenlinna, Finland: Duodecim; 2006: 589-603. .
Cited by
Sorted by citations
Items 201–277 of 277
Begünstigen Antidepressiva die Suizidalität und die Suizidrate von Depressiven?
Hättenschwiler, J., Baumann, P., Hatzinger, M., Höck, P., HolsboerTrachsler, E., Jost, M., Nil, R., Ramseier, F., Seifritz, E., ZULLINO, D. F., et al. (2007) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2007.06287 · Cited by 2
[Celecoxib vs indomethacin and acute gastric lesions in rats].
Laudanno, O. M. O., Esnarriaga, J., Cesolari, J. A., Maglione, C. B., Aramberry, L. J., Sambrano, J. S., Piombo, G., & Rista, L. (2000) · PubMed · Cited by 2
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_88-1 · Cited by 2
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_19 · Cited by 2
Psychopharmacology for Pediatric Depressive Disorders
Rengasamy, M. L., Shalev, A., & Birmaher, B. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_16 · Cited by 2
Antidepressants and Suicide Prevention
Goldney, R. D. (2011) · doi:10.1002/9781119998556.ch26 · Cited by 2
Glassman, A. H., & Bigger, J. T. (2010) · Wiley eBooks · doi:10.1002/9780470972304.ch5 · Cited by 2
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_2 · Cited by 1
Yang, J. H., Kim, M. J., Rhee, S. J., Lee, H., Kim, Y., Lee, B., & Ahn, Y. M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122364 · Cited by 1
Cazal, L. B. (2015) · Cited by 1
Termorshuizen, F., Palmen, S. J. M. C., & Heerdink, E. R. (2015) · PubMed · Cited by 1
Mental Health Retrosight: Case studies
Pollitt, A., Diepeveen, S., Guthrie, S., Morgan Jones, M., Ni Chonaill, S., Olmsted, S. S., Schultz, D., Pincus, H. A., Grant, J., & Wooding, S. (2013) · RAND Corporation eBooks · doi:10.7249/rr452 · Cited by 1
Cannabis and Neuropsychiatric Effects
Rettew, D. C., Gundersen, D. C., Rapp, E. K., Riggs, P., Miller, C. L., Jackson, M., Sabet, K. A., Cort, B., & Bader, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_4 · Cited by 1
Reducing the suicide rate in people with mental health problems
(2007) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.41 · Cited by 1
Olié, J., Mouren, M., Adolphe, M., Allilaire, J., Baulieu, E. E., Cambier, J., Falissard, B., Hamon, M., Lôo, H., Mouren, M., et al. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31291-9 · Cited by 1
Factores de riesgo de las conductas suicidas en adolescentes, revisión de la literatura
Muñoz, A. C., Rodríguez-Caballero, A., Velasco-Rojano, Á. E., Sánchez-Olivera, K., Valdespino, D. M., & García-Piña, C. A. (2024) · Acta Pediátrica de México · doi:10.18233/apm.v45i1s.2753 · Cited by 2
Termorshuizen, F., Smeets, H. M., Boks, M. P., & Heerdink, E. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116639752 · Cited by 1
Antidepressants and Suicide Risk: A Challenge
Pompili, M., Giordano, G., & Lamis, D. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_24 · Cited by 1
Psychopharmacology in the Treatment of Patients with Cardiovascular Disease
Beach, S. R., Celano, C. M., Huffman, J. C., & Stern, T. A. (2016) · Springer eBooks · doi:10.1007/978-981-287-206-7_53 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Duvenhage, I. (2010) · Boloka Institutional Repository (North-west University) · Cited by 1
Biological Treatment of Mood Disorders
Allan, C. L., Topiwala, A., Ebmeier, K. P., Semple, D. M., & Steele, J. D. (2013) · Wiley eBooks · doi:10.1002/9781118316153.ch6 · Cited by 1
Suicide and mortality related to mental disorder in three Swedish cohorts
Tidemalm, D. (2010) · Figshare · Cited by 1
Thrasher, S. M. (2010) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16984594 · Cited by 1
Föreningen, S. P. (2009) · Cited by 1
BOLAND, R. J., Gaud, K. G., & Keller, M. B. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch103 · Cited by 1
4 Richtlijnen voor de behandeling van suïcidale patiënten
Huisman, A., & Kerkhof, A. J. F. M. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7804-3_4
El-Mallakh, R., Roberts, R. J., & El-Mallakh, P. (2014) · Springer eBooks · doi:10.1007/978-88-470-1738-2_5
Unipolare Depression–Pharmakitherapie und Psychotherapie (ICD-10 F3)
Schmauß, M., Schramm, E., & Berger, T. (2008) · Elsevier eBooks · doi:10.1016/b978-343724780-4.50011-7
Gender and Drug Type Linked to Suicidal Thoughts
Yan, J. (2009) · Psychiatric News · doi:10.1176/pn.44.23.psychnews_44_23_030
M, I. P., M, L. F., & G, C. M. (2011) · Revista chilena de pediatría · doi:10.4067/s0370-41062011000400002
La notion de responsabilité criminelle à l’ère des antidépresseurs
Saint-Germain, C. (2010) · Frontières · doi:10.7202/039452ar
Antidepressants and Suicide: Putting the Risk in Perspective
Howland, R. H. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080301-03
Brugioni, L., Magnani, P., Berti, E., Gozzi, C., Niederhausern, F. D., & Zandomeneghi, R. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2009.93
Childhood intelligence and being a vegetarian
Richards, M. (2007) · BMJ · doi:10.1136/bmj.39107.671412.80
Muhonen, L. H. (2008) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
WPA Section on Pharmacopsychiatry: consensus statement
Baldwin, D. S., Goodwin, G. M., Kasper, S. F., Okasha, A., Stein, D. J., Tandon, R., & Versiani, M. (2008)
Psychopharmacology in the Treatment of Patients with Cardiovascular Disease
Beach, S. R., Celano, C. M., Huffman, J. C., & Stern, T. A. (2015) · Springer eBooks · doi:10.1007/978-981-4560-53-5_53-1
Medicamentos y conducta suicida: un estudio de casos y controles
Fructuoso, A. (2016) · doi:10.35376/10324/16382
Ballenger, J. C. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70791-6
Do Antidepressants Make Patients Suicidal
Dubovsky, S. L. (2007) · Journal watch · doi:10.1056/jp200701290000001
Methods for the Post-Marketing Monitoring of Psychotropics Safety: Interests and Pitfalls
Salvo, F., Fourrier‐Réglat, A., Moore, N. D., Bégaud, B., & Pariente, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_3
Evaluations of multivalued treatments
Hong, G. (2015) · doi:10.1002/9781119030638.ch5
(2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343664_0006
Richtlijnen voor de behandeling van suïcidale patiënten
Huisman, A., van Houwelingen, C. A. J., & Kerkhof, A. J. F. M. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0972-6_4
Neurobiology and Pharmacological Prevention of Suicide in Mood Disorders
Gonda, X., Rihmer, Z., & Döme, P. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_32
Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
Serafini, G., Solano, P., & Amore, M. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_31
The Progression of Serious Mental Disorders to Mortality in Primary Care
Vallerand, I. A. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28283
Conduites suicidaires à l'adolescence
Mirkovic, B., Podlipski, M.-A., & Gérardin, P. (2019) · Time to knit · doi:10.1016/s0246-1072(19)63168-8
What Is Suicidal Behavior, and Can It Be Prevented?
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.002
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.008
I Predict, Therefore I Cannot Be
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.009
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.010
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.004
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.011
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.007
I Think, Therefore I Do Not Want to Be
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.006
(2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.013
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.794
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.015
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.001
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1378
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.005
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.012
(2012) · Wiley eBooks · doi:10.1002/9781119977452.refs
Suhr, C. (2019) · Manchester University Press eBooks · doi:10.7765/9781526140326.00017
Fanthorpe, U. A. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.15.1.22
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.014
Neuroscience of Violence and Suicidal Behavior
Ludwig, B., & Dwivedi, Y. (2026) · Wiley eBooks · doi:10.1002/9781118832202.ch16
Socransky, O., Friedman, Z., Gutterman, D. D., Shinfeld, A., Koren, D., Rimon, J., Kumbhare, D. A., Clarke, H. A., Slepian, P. M., Lidor, R., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001447
Ryan, M., & Nemeroff, C. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139519502.030
Metadata
- Authors
- Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., & Haukka, J.
- Affiliations
- Niuvanniemi Hospital (FI)
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2006-12-01
- Volume
- 63
- Issue
- 12
- Pages
- 1358-67
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2151499150
- Cited by
- 277
- References
- 38
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 21 · 2017: 5 · 2016: 19 · 2015: 16 · 2014: 19 · 2013: 12 · 2012: 16
- FWCI
- 28.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressants, suicide, suicide attempts, mortality, fluoxetine, venlafaxine, paroxetine, selective serotonin reuptake inhibitors, cardiovascular mortality, cerebrovascular disease mortality, adolescents, depression treatment
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Cause of Death, Child, Depressive Disorder, Female, Finland, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Registries, Risk Factors, Suicide, Suicide, Attempted, Cohort Studies, Proportional Hazards Models, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review